|Mr. Lawrence J. Jasinski BS, MBA||CEO & Director||648.52k||N/A||1957|
|Ms. Miri Pariente||VP of Operations, Regulatory & Quality||321.75k||N/A||1977|
|Ms. Jeannine Lynch||VP of Market Access & Strategy||422.25k||N/A||1965|
|Mr. David Hexner||VP of R&D||244.05k||N/A||N/A|
|Mr. Almog Adar||Director of Fin. & Corp. Financial Controller||N/A||N/A||1984|
|Ms. Kathleen O'Donnell||VP of Marketing & New Bus. Devel.||N/A||N/A||N/A|
|Ms. Judy Kula||VP of Customer Service, HR & Bus. Affairs||N/A||N/A||N/A|
|Mr. Ami Kraft||Exec. Advisor to the CEO||N/A||N/A||1943|
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
ReWalk Robotics Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.